MCRB offering history
Every offering-related filing in Seres Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 716 filings back to Jun 9, 2014.
| Date | Filing | What it means | |
|---|---|---|---|
| Aug 13, 2026 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Aug 4, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 11, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Oct 11, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 1, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 1, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Aug 6, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 15, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 8, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Apr 27, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 30, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 6, 2022 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 21, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 17, 2020 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Aug 14, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 14, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 13, 2020 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Aug 13, 2020 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Aug 11, 2020 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Aug 11, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 18, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 18, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 9, 2020 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Nov 27, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 14, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 12, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 24, 2017 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 16, 2017 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jun 26, 2015 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jun 25, 2015 | S-1MEF → | REGISTERED | S-1MEF registration — capacity to sell shares, not a sale yet |
| Jun 25, 2015 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 24, 2015 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jun 16, 2015 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| May 27, 2015 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
MCRB offering FAQ
When did MCRB last execute an offering?
Per SEC filings, Seres Therapeutics, Inc.'s most recent priced offering document is a 424B5 filed 2026-08-04. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did MCRB last announce or register an offering?
The most recent registration is a S-3 filed 2026-08-13. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.